Use of rhG-CSF in the collection of peripheral blood stem cells for autologous blood stem cell transplantation in acute myeloblastic leukemia

M Jurado; C Delgado; A Moratalla; D Casero; S Oyonarte; J M de Pablos

Use of rhG-CSF in the collection of peripheral blood stem cells for autologous blood stem cell transplantation in acute myeloblastic leukemia

Bone Marrow Transplant. 1996 Oct;18(4):821-2.

Authors

M Jurado¹, C Delgado, A Moratalla, D Casero, S Oyonarte, J M de Pablos

Affiliation

¹ Servicio de Hematología, Hospital Virgen de las Nieves, Granada, Spain.

PMID: 8899205

Abstract

The use of recombinant granulocyte colony-stimulating factor (rhG-CSF) alone is attractive for the collection of peripheral blood stem cells (PBSC) in several malignancies. In acute myeloblastic leukemia (AML), not enough experience has been gained with rhG-CSF and leukapheresis is more common after recovery from antileukemia chemotherapy. This is the case report of a patient who received rhG-CSF alone to mobilize stem cells where the cells collected in the leukapheresis bag had a blastic immunophenotype.

Publication types

Case Reports

MeSH terms

Granulocyte Colony-Stimulating Factor / adverse effects
Granulocyte Colony-Stimulating Factor / therapeutic use*
Hematopoietic Stem Cell Transplantation / methods*
Hematopoietic Stem Cells / drug effects*
Hematopoietic Stem Cells / immunology
Humans
Leukapheresis / methods*
Leukemia, Myeloid, Acute / therapy*
Male
Middle Aged
Neoplastic Stem Cells / drug effects
Neoplastic Stem Cells / immunology
Phenotype
Recombinant Proteins
Transplantation, Autologous

Substances

Recombinant Proteins
Granulocyte Colony-Stimulating Factor